Kowalewski Mariusz, Pasierski Michał, Litwinowicz Radosław, Zembala Marian, Piekuś-Słomka Natalia, Tobota Zdzisław, Maruszewski Bohdan, Suwalski Piotr
Department of Cardiac Surgery, Central Clinical Hospital of the Ministry of Interior, Centre of Postgraduate Medical Education, Warsaw, Poland; Innovative Medical Forum, Thoracic Research Centre, Collegium Medicum Nicolaus Copernicus University, Bydgoszcz, Poland; Cardio-Thoracic Surgery Department, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, the Netherlands.
Department of Cardiac Surgery, Central Clinical Hospital of the Ministry of Interior, Centre of Postgraduate Medical Education, Warsaw, Poland.
Semin Thorac Cardiovasc Surg. 2021 Winter;33(4):974-983. doi: 10.1053/j.semtcvs.2020.11.015. Epub 2020 Nov 12.
Observational studies suggest improved outcomes with multiple (MAG) as compared to single arterial grafting (SAG) in patients with multivessel coronary artery disease and undergoing coronary artery bypass grafting (CABG). Even though around 6% of CABG patients have preoperative atrial fibrillation, previous studies did not address MAG versus SAG comparison in this setting. Data from KROK (Polish National Registry of Cardiac Surgery Procedures) were retrospectively collected. 5738 patients with multivessel coronary artery disease and AF (77.9% men, mean age 69.0 ± 8.0) undergoing isolated CABG surgery between 2006 and 2019 in 37 reference centers across Poland were analyzed. Propensity score matching was performed. Primary endpoint was mid-term survival. Median follow-up was 5 years ([IQR 1.9-7.6], max.13). One-to-three Propensity score matching included 2364 patients divided into MAG (591) and SAG (1773) subsets. Subjects were no different in terms of baseline risk and surgical characteristics. Number of distal anastomoses was 2.82 ± 0.83 versus 2.80 ± 0.75 (P = 0.516) for MAG and SAG, respectively. In-hospital outcomes and mortality risk at 1-year (hazard ratio, 95% confidence intervals: 1.13 [0.81-1.58]; P = 0.469) was unchanged with MAG. Multiple arterial grafting was associated with 20% improved mid-term survival: HR 0.80; (95% confidence intervals: 0.65-0.97); P = 0.026. Benefit was sustained in subgroup analyses, yet most appraised in low risk patients (<70-year-old; EuroSCORE <2; no diabetes) and when complete revascularization was achieved. Multiple as compared to single arterial grafting in atrial fibrillation patients undergoing CABG is safe and associated with improved mid-term survival. A particular survival benefit was observed in lower risk patients.
观察性研究表明,在多支冠状动脉疾病且接受冠状动脉旁路移植术(CABG)的患者中,与单支动脉移植(SAG)相比,多支动脉移植(MAG)的预后更佳。尽管约6%的CABG患者术前患有房颤,但既往研究未涉及这种情况下MAG与SAG的比较。回顾性收集了来自KROK(波兰国家心脏外科手术登记处)的数据。分析了2006年至2019年期间在波兰37个参考中心接受单纯CABG手术的5738例多支冠状动脉疾病合并房颤患者(77.9%为男性,平均年龄69.0±8.0岁)。进行了倾向评分匹配。主要终点是中期生存率。中位随访时间为5年([四分位间距1.9 - 7.6],最长13年)。1对3倾向评分匹配纳入了2364例患者,分为MAG(591例)和SAG(1773例)亚组。受试者在基线风险和手术特征方面无差异。MAG和SAG的远端吻合口数量分别为2.82±0.83和2.80±0.75(P = 0.516)。MAG组的住院结局和1年死亡率风险(风险比,95%置信区间:1.13 [0.81 - 1.58];P = 0.469)未改变。多支动脉移植与中期生存率提高20%相关:风险比0.80;(95%置信区间:0.65 - 0.97);P = 0.026。在亚组分析中该益处持续存在,但在低风险患者(<70岁;欧洲心脏手术风险评估系统<2;无糖尿病)以及实现完全血运重建时最为明显。在接受CABG的房颤患者中,与单支动脉移植相比,多支动脉移植是安全的,且与中期生存率提高相关。在低风险患者中观察到了特别的生存益处。